• 1. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 2. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 3. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Phenylpyridines

Recent Advances in the Study of 2-Methyl-5-phenylnicotinonitrile (CAS: 63820-78-0) in Chemical Biology and Pharmaceutical Research

2-Methyl-5-phenylnicotinonitrile (CAS: 63820-78-0) is a heterocyclic compound that has garnered significant attention in recent years due to its potential applications in medicinal chemistry and drug discovery. This compound, characterized by its phenyl and nitrile substituents on a pyridine backbone, has been investigated for its diverse biological activities and its role as a key intermediate in the synthesis of pharmacologically active molecules. Recent studies have explored its utility in targeting various disease pathways, making it a compound of interest for researchers in the field of chemical biology and pharmaceutical sciences.

One of the most notable advancements in the study of 2-Methyl-5-phenylnicotinonitrile is its application in the development of kinase inhibitors. Kinases are critical enzymes involved in signal transduction pathways, and their dysregulation is often associated with cancer and other diseases. Recent research has demonstrated that derivatives of 2-Methyl-5-phenylnicotinonitrile exhibit potent inhibitory activity against specific kinases, such as EGFR (Epidermal Growth Factor Receptor) and VEGFR (Vascular Endothelial Growth Factor Receptor). These findings suggest that this compound could serve as a promising scaffold for the design of novel anticancer agents.

In addition to its role in kinase inhibition, 2-Methyl-5-phenylnicotinonitrile has also been explored for its potential as an anti-inflammatory agent. A study published in the Journal of Medicinal Chemistry reported that certain derivatives of this compound exhibited significant inhibition of pro-inflammatory cytokines, such as TNF-α and IL-6. These results highlight the compound's potential in the treatment of inflammatory diseases, including rheumatoid arthritis and inflammatory bowel disease. The mechanism of action appears to involve the modulation of NF-κB signaling, a key pathway in the inflammatory response.

Another area of interest is the use of 2-Methyl-5-phenylnicotinonitrile in the synthesis of heterocyclic compounds with antimicrobial properties. Researchers have successfully utilized this compound as a building block to create novel derivatives with activity against a range of bacterial and fungal pathogens. For instance, a recent study in Bioorganic & Medicinal Chemistry Letters described the synthesis of a series of 2-Methyl-5-phenylnicotinonitrile derivatives that showed potent activity against methicillin-resistant Staphylococcus aureus (MRSA), a major concern in hospital-acquired infections.

The chemical versatility of 2-Methyl-5-phenylnicotinonitrile is further underscored by its role in the development of fluorescent probes for biological imaging. A study in Analytical Chemistry demonstrated that this compound could be modified to create highly selective and sensitive probes for detecting metal ions in biological systems. Such probes are invaluable tools for studying metal homeostasis and its implications in diseases like Alzheimer's and Parkinson's.

Despite these promising developments, challenges remain in the optimization of 2-Methyl-5-phenylnicotinonitrile-based compounds for clinical use. Issues such as bioavailability, metabolic stability, and toxicity need to be addressed through further structure-activity relationship (SAR) studies. Nevertheless, the compound's multifaceted applications in drug discovery and chemical biology make it a valuable subject of ongoing research.

In conclusion, 2-Methyl-5-phenylnicotinonitrile (CAS: 63820-78-0) represents a versatile and promising compound in the field of chemical biology and pharmaceutical research. Its applications span from kinase inhibition and anti-inflammatory activity to antimicrobial properties and biological imaging. As research continues to uncover new uses and optimize its derivatives, this compound is likely to play an increasingly important role in the development of novel therapeutics and diagnostic tools.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)